Decrease in normal human corneal sensitivity with topical diclofenac sodium.

K Szerenyi; K Sorken; J J Garbus; M Lee; P J McDonnell

doi:10.1016/s0002-9394(14)72954-x

Home/Archive/PubMed

PubMed · 8085587

Decrease in normal human corneal sensitivity with topical diclofenac sodium.

K Szerenyi·K Sorken·J J Garbus·M Lee·P J McDonnell

View original source ↗Export metadata ↓

Abstract

We tested the effect of topical diclofenac sodium on corneal sensitivity in the human eye. Corneal sensitivity was measured in ten adult subjects with the Cochet-Bonnet esthesiometer before, and immediately after, applying one drop of diclofenac sodium 0.1% in one eye and one drop of diclofenac vehicle in the other eye. Application was repeated every five minutes for 20 minutes; then no more drops were applied, and corneal sensitivity was measured every 15 minutes until sensitivity measurements returned to baseline levels. Diclofenac sodium decreased corneal sensitivity significantly (P = .0001) in all ten subjects, compared with eyes treated with the vehicle. The effect of diclofenac sodium increased as additional drops were administered. After the drug instillation was stopped, corneal sensitivity returned to baseline measurements within less than an hour in all the subjects. Diclofenac sodium substantially lowers sensitivity in normal, unoperated-on human corneas; the vehicle has no measurable effect on sensitivity.

Explore related subjects

Administration, Topical Adult Analysis of Variance Cornea Diclofenac Humans Ophthalmic Solutions Ophthalmology Trigeminal Nerve Clinical Trial Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

K Szerenyi, K Sorken, J J Garbus, M Lee, P J McDonnell. 1994-09-15. Decrease in normal human corneal sensitivity with topical diclofenac sodium.. https://doi.org/10.1016/s0002-9394(14)72954-x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate.

PURPOSE: Dermal application of immunosuppressants can be an effective means of achieving site-specific immunosuppression (SITE) on skin allografts in burn wound management and in the treatment of various immune skin disorders. We have previously reported success with topical cyclosporine A (tCsA) in the treatment of skin allograft rejection in rats. Using a new tCsA formulation with a penetration enhancer (PE), polyethylene glycol-8 (PEG-8) glyceryl caprylate/caprate (Labrasol, Gattefossé, St. Priest, France), in a trinary drug delivery system, we hypothesized that we would induce SITE and significantly delay rejection of dual skin allografts in rats. METHODS: Dual rat skin allografts from Lewis x Brown-Norway (LBN) donors were grafted to Lewis (Lew) recipients. Experimental animals (EXP, n = 7) received a 10-day course of systemic cyclosporine (sCsA, 8 mg/kg/day) followed by topical application. One of the two allografts on each experimental animal received tCsA/PE application (5 mg/kg/day) until sacrifice (tCsA/PE-treated). The other allograft received vehicle only (vehicle-treated). Allogeneic controls (ALLO-CON, n = 9) received no sCsA or tCsA. First signs of rejection were determined based on the initial observation of erythema, hair loss, flakiness, and/or scabs. RESULTS: The mean time to rejection for ALLO-CON allografts was 6.3 +/- 0.7 days (t test, P = 0.0013); for vehicle-treated allografts, 12.3 +/- 3.8 days (paired t test, P = 0.0146); and for tCsA/PE-treated allografts, 25.6 +/- 5.4 days. The disparity of days to rejection between dual allografts in the ALLO-CON group was 0.0 +/- 0.0 day and that between the tCsA/PE- and vehicle-treated dual allografts was 13.3 +/- 3.9 days (t test, P = 0.0016). CONCLUSIONS: A new formulation of tCsA in a trinary drug delivery system is successful at delaying the onset of rejection in dual skin allografts in rats by SITE, and PEG-8 glyceryl caprylate/caprate may represent a potentially effective transdermal penetration enhancer.

Administration, Topical↗

PubMed1999

Presumed clostridial and aerobic bacterial infections of the cornea in two horses.

Microscopic examination of Gram-stained tissue specimens collected from severe corneal ulcers in 2 horses revealed large gram-positive rods suggestive of Clostridium spp. Clostridium perfringens was isolated from specimens collected from horse 1; anaerobic organisms were not detected in specimens from horse 2. Aerobic bacterial culture revealed Aeromonas hydrophila and Enterobacter cloacae in specimens collected from horses 1 and 2, respectively. An insect exoskeleton was presumed to be the underlying cause of ulceration in horse 1. Cause of ulceration in horse 2 was not determined. Antibiotics used to treat the corneal infections included ticarcillin disodium-clavulanic acid injected one time subconjunctivally and chloramphenicol applied topically at frequent intervals. Horse 2 also received penicillin or trimethoprim-sulfadiazine. Small leukomas were the only lesion remaining between 2 and 7 months after initial evaluation. Chloramphenicol applied topically appears to be an effective treatment against clostridial corneal infections in horses.

Administration, Topical↗

PubMed1999

Topical delivery of caffeine from some commercial formulations.

Permeation of caffeine through human skin and artificial membranes (mounted in modified Franz type diffusion cells) was evaluated, either from saturated solutions or from commercially available topical formulations (all containing 3% caffeine). Data interpretation of the caffeine diffusion through human skin does not implicate transfer through pores despite caffeine being a relatively polar molecule. No correlation was found between transfer though the synthetic membranes (cellulose acetate impregnated with isopropyl myristate and silicone rubber soaked in isopropyl myristate) and that observed through skin. The synthetic membranes can be used for assessing product performance in quality assurance but will give little indication of its performance in vivo. The study investigated the percutaneous permeation of caffeine through human skin in order to obtain a mechanistic interpretation of its route of permeation. Synthetic membranes were also examined to determine if they could be used as models for human skin. Different commercial formulations investigated to determine the significance of enhancement strategies.

Administration, Topical↗